{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Encorafenib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Encorafenib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Encorafenib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "encorafenib",
    "trial_2_text": "Encorafenib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Encorafenib Supplement: 60 participants will take Encorafenib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Encorafenib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Encorafenib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.372050017118454,
      "189": 0.3447873294353485,
      "188": 0.2989899814128876,
      "123": 0.28271836042404175,
      "20": 0.2544996738433838,
      "78": 0.2543567419052124,
      "17": 0.2156856209039688,
      "64": 0.20495785772800446,
      "177": 0.1993570625782013,
      "228": 0.17878331243991852,
      "37": 0.17292876541614532,
      "49": 0.17003531754016876,
      "21": 0.1670360118150711,
      "173": 0.1615743190050125,
      "29": 0.1578417718410492,
      "101": 0.15451005101203918,
      "68": 0.1487397998571396,
      "9": 0.14662964642047882,
      "261": 0.14458513259887695,
      "77": 0.13949474692344666,
      "67": 0.1392342895269394,
      "38": 0.12709546089172363,
      "46": 0.1270289421081543,
      "179": 0.1254328191280365,
      "200": 0.1235884577035904,
      "14": 0.11869599670171738,
      "239": 0.10848421603441238,
      "350": 0.10664670169353485,
      "2": 0.10659939050674438,
      "114": 0.1060672253370285,
      "341": 0.09945142269134521,
      "104": 0.09864754974842072,
      "36": 0.0970965027809143,
      "193": 0.09633737057447433,
      "131": 0.09527940303087234,
      "191": 0.08932743966579437,
      "136": 0.08660445362329483,
      "396": 0.08588804304599762,
      "85": 0.08293665945529938,
      "343": 0.08220604807138443,
      "249": 0.08214963227510452,
      "79": 0.0819774940609932,
      "30": 0.08193705976009369,
      "122": 0.08058076351881027,
      "27": 0.08047559857368469,
      "180": 0.08015865087509155,
      "126": 0.08005641400814056,
      "194": 0.0795174092054367,
      "186": 0.07913915812969208,
      "243": 0.07875087112188339,
      "151": 0.07631546258926392,
      "76": 0.07595851272344589,
      "130": 0.07436025887727737,
      "28": 0.07342881709337234,
      "5": 0.07329227030277252,
      "257": 0.07069986313581467,
      "72": 0.07021420449018478,
      "61": 0.07017799466848373,
      "116": 0.0695129781961441,
      "147": 0.0678696259856224,
      "234": 0.0669669434428215,
      "33": 0.06656723469495773,
      "35": 0.06617122888565063,
      "355": 0.06573335081338882,
      "82": 0.0653773844242096,
      "269": 0.0645608976483345,
      "139": 0.06190043315291405,
      "86": 0.06179927662014961,
      "102": 0.0604473315179348,
      "253": 0.05951252952218056,
      "204": 0.05881286785006523,
      "211": 0.05764545500278473,
      "212": 0.05749170482158661,
      "96": 0.056607477366924286,
      "351": 0.05585244297981262,
      "100": 0.055204249918460846,
      "356": 0.05455438792705536,
      "441": 0.05451258271932602,
      "288": 0.05448555201292038,
      "454": 0.05260078236460686,
      "18": 0.05078030005097389,
      "144": 0.05074712261557579,
      "371": 0.050419192761182785,
      "282": 0.050366852432489395,
      "142": 0.04971592500805855,
      "213": 0.049438465386629105,
      "221": 0.048561811447143555,
      "1": 0.0484125129878521,
      "4": 0.048250261694192886,
      "154": 0.04774504154920578,
      "276": 0.0472785048186779,
      "466": 0.04697154834866524,
      "97": 0.0454179048538208,
      "98": 0.04515158385038376,
      "163": 0.04514782130718231,
      "535": 0.04477662965655327,
      "286": 0.04452101141214371,
      "75": 0.04438939318060875,
      "92": 0.044129155576229095,
      "361": 0.04399945214390755
    },
    "trial_2_ae": {
      "87": 0.372050017118454,
      "189": 0.3447873294353485,
      "188": 0.2989899814128876,
      "123": 0.28271836042404175,
      "20": 0.2544996738433838,
      "78": 0.2543567419052124,
      "17": 0.2156856209039688,
      "64": 0.20495785772800446,
      "177": 0.1993570625782013,
      "228": 0.17878331243991852,
      "37": 0.17292876541614532,
      "49": 0.17003531754016876,
      "21": 0.1670360118150711,
      "173": 0.1615743190050125,
      "29": 0.1578417718410492,
      "101": 0.15451005101203918,
      "68": 0.1487397998571396,
      "9": 0.14662964642047882,
      "261": 0.14458513259887695,
      "77": 0.13949474692344666,
      "67": 0.1392342895269394,
      "38": 0.12709546089172363,
      "46": 0.1270289421081543,
      "179": 0.1254328191280365,
      "200": 0.1235884577035904,
      "14": 0.11869599670171738,
      "239": 0.10848421603441238,
      "350": 0.10664670169353485,
      "2": 0.10659939050674438,
      "114": 0.1060672253370285,
      "341": 0.09945142269134521,
      "104": 0.09864754974842072,
      "36": 0.0970965027809143,
      "193": 0.09633737057447433,
      "131": 0.09527940303087234,
      "191": 0.08932743966579437,
      "136": 0.08660445362329483,
      "396": 0.08588804304599762,
      "85": 0.08293665945529938,
      "343": 0.08220604807138443,
      "249": 0.08214963227510452,
      "79": 0.0819774940609932,
      "30": 0.08193705976009369,
      "122": 0.08058076351881027,
      "27": 0.08047559857368469,
      "180": 0.08015865087509155,
      "126": 0.08005641400814056,
      "194": 0.0795174092054367,
      "186": 0.07913915812969208,
      "243": 0.07875087112188339,
      "151": 0.07631546258926392,
      "76": 0.07595851272344589,
      "130": 0.07436025887727737,
      "28": 0.07342881709337234,
      "5": 0.07329227030277252,
      "257": 0.07069986313581467,
      "72": 0.07021420449018478,
      "61": 0.07017799466848373,
      "116": 0.0695129781961441,
      "147": 0.0678696259856224,
      "234": 0.0669669434428215,
      "33": 0.06656723469495773,
      "35": 0.06617122888565063,
      "355": 0.06573335081338882,
      "82": 0.0653773844242096,
      "269": 0.0645608976483345,
      "139": 0.06190043315291405,
      "86": 0.06179927662014961,
      "102": 0.0604473315179348,
      "253": 0.05951252952218056,
      "204": 0.05881286785006523,
      "211": 0.05764545500278473,
      "212": 0.05749170482158661,
      "96": 0.056607477366924286,
      "351": 0.05585244297981262,
      "100": 0.055204249918460846,
      "356": 0.05455438792705536,
      "441": 0.05451258271932602,
      "288": 0.05448555201292038,
      "454": 0.05260078236460686,
      "18": 0.05078030005097389,
      "144": 0.05074712261557579,
      "371": 0.050419192761182785,
      "282": 0.050366852432489395,
      "142": 0.04971592500805855,
      "213": 0.049438465386629105,
      "221": 0.048561811447143555,
      "1": 0.0484125129878521,
      "4": 0.048250261694192886,
      "154": 0.04774504154920578,
      "276": 0.0472785048186779,
      "466": 0.04697154834866524,
      "97": 0.0454179048538208,
      "98": 0.04515158385038376,
      "163": 0.04514782130718231,
      "535": 0.04477662965655327,
      "286": 0.04452101141214371,
      "75": 0.04438939318060875,
      "92": 0.044129155576229095,
      "361": 0.04399945214390755
    }
  },
  "safety": {
    "trial_1_safety": 0.4497985541820526,
    "trial_2_safety": 0.4497985541820526
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4832732081413269
  }
}